...
首页> 外文期刊>Bone marrow transplantation >Indiscernible benefit of high-resolution HLA typing in improving long-term clinical outcome of unrelated umbilical cord blood transplant.
【24h】

Indiscernible benefit of high-resolution HLA typing in improving long-term clinical outcome of unrelated umbilical cord blood transplant.

机译:高分辨率HLA分型在改善无关脐带血移植的长期临床疗效方面没有明显的益处。

获取原文
获取原文并翻译 | 示例
           

摘要

The success of allogeneic hematopoietic stem cell transplantation depends in part on the accuracy of human leukocyte antigen (HLA) matching between the donor-recipient pair. The higher the number of matching HLA alleles, the smaller the chance that the transplant recipient will develop complications. Umbilical cord blood (UCB) transplantation was noted to result in a remarkably low frequency and severity of graft-versus-host disease (GvHD) and graft rejection compared to that in unrelated bone marrow transplant recipients. At present most banks match UCB donors for respective recipients by HLA-A, -B low-resolution typing and -DRB1 high-resolution typing. We retrospectively conducted high-resolution sequence-based HLA typing on DNA samples available from 65 Chinese UCB-recipient pairs typed previously by using low-resolution sequence-specific oligonucleotide probes and sequence-specific primers, and evaluated the clinical outcome. High-resolution typing revealed imperceptible HLA alleles that were hardly identified in low-resolution typing. Univariate analyses demonstrated no significant correlation between the extents of high-resolution HLA disparity with engraftment, graft failure, acute GvHD, transplant-related mortality and long-term 6-year overall survival. Data from the study suggest that high-resolution typing for HLA-A, -B and -DRB1 contributed no substantial improvement to UCB transplant outcome. Low-resolution typing appears to be amenable to matching UCB-recipient pairs without compromising the quality of transplant.
机译:同种异体造血干细胞移植的成功部分取决于供体-受体对之间人类白细胞抗原(HLA)匹配的准确性。匹配的HLA等位基因数量越多,移植受体发生并发症的机会就越小。与不相关的骨髓移植受者相比,脐带血(UCB)移植导致移植物抗宿主病(GvHD)和移植物排斥的频率和严重性明显降低。目前,大多数银行通过HLA-A,-B低分辨率键入和-DRB1高分辨率键入来为各自的接收者匹配UCB供者。我们使用低分辨率序列特异性寡核苷酸探针和序列特异性引物,对先前从65种中国UCB受体对中获得的DNA样品进行了高分辨率的基于序列的HLA分型,并评估了临床结果。高分辨率分型显示了难以分辨的HLA等位基因,而在低分辨率分型中几乎没有发现。单因素分析表明,高分辨率HLA差异与移植,移植失败,急性GvHD,移植相关死亡率和长期6年总生存率之间无显着相关性。该研究的数据表明,HLA-A,-B和-DRB1的高分辨率分型对UCB移植结果没有实质性改善。低分辨率分型似乎适合匹配UCB受体对,而不会影响移植质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号